Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
Moderna’s technology platform makes it possible to direct cells to express proteins without changing their genome or creating long term safety concerns.
Headlines from Mass High Tech about MODERNA THERAPEUTICS INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Other Business Offering | In Vitro Diagnostics |
| Year Established | 2010 |
| Ownership Type | Private |
| Stephane Bancel | President/Founding CEO | |||
| Gregg Beloff | CFO | |||
| Tony deFougerolles | CSO | |||
| Eric Huang | Sr Director Strategy/Business Dev't |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Website | http://www.modernatx.com |
| Revenue | Subscriber access only |
| Address | 161 First St Cambridge, MA, 02142 |
| Phone | 617-714-6500 |
| Subscriber access only | |
| Website | www.modernatx.com |
© 2012 American City Business Journals. All rights reserved. Use of this Site constitutes acceptance of our User Agreement (updated 3/14/12) and Privacy Policy (updated 3/14/12).
Your California Privacy Rights.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.